211 related articles for article (PubMed ID: 26947138)
1. Second vs. First generation drug eluting stents in multiple vessel disease and left main stenosis: Two-year follow-up of the observational, prospective, controlled, and multicenter ERACI IV registry.
Haiek C; Fernández-Pereira C; Santaera O; Mieres J; Rifourcat I; Lloberas J; Larribau M; Pocoví A; Rodriguez-Granillo AM; Sarmiento RA; Antoniucci D; Rodriguez AE
Catheter Cardiovasc Interv; 2017 Jan; 89(1):37-46. PubMed ID: 26947138
[TBL] [Abstract][Full Text] [Related]
2. Second vs. first-generation drug-eluting stents in complex lesions subsets: 3 years' follow-up of ERACI IV study.
Rodriguez AE; Santaera O; Larribau M; Sarmiento R; Haiek C; Del Pozo JF; Pavlovsky H; Rodriguez-Granillo AM;
Minerva Cardioangiol; 2017 Feb; 65(1):81-90. PubMed ID: 27784884
[TBL] [Abstract][Full Text] [Related]
3. Second versus first generation DES in multiple vessel disease and unprotected left main stenosis: insights from ERACI IV Study.
Rodriguez AE
Minerva Cardioangiol; 2015 Aug; 63(4):317-27. PubMed ID: 25780954
[TBL] [Abstract][Full Text] [Related]
4. The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery Disease.
Chieffo A; Tanaka A; Giustino G; Briede I; Sawaya FJ; Daemen J; Kawamoto H; Meliga E; D'Ascenzo F; Cerrato E; Stefanini GG; Capodanno D; Mangiameli A; Templin C; Erglis A; Morice MC; Mehran R; Van Mieghem NM; Nakamura S; De Benedictis M; Pavani M; Varbella F; Pisaniello M; Sharma SK; Tamburino C; Tchetche D; Colombo A;
JACC Cardiovasc Interv; 2017 Dec; 10(23):2401-2410. PubMed ID: 29217002
[TBL] [Abstract][Full Text] [Related]
5. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
[TBL] [Abstract][Full Text] [Related]
6. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
[TBL] [Abstract][Full Text] [Related]
7. Left Main Stenting in Comparison With Surgical Revascularization: 10-Year Outcomes of the (Left Main Coronary Artery Stenting) LE MANS Trial.
Buszman PE; Buszman PP; Banasiewicz-Szkróbka I; Milewski KP; Żurakowski A; Orlik B; Konkolewska M; Trela B; Janas A; Martin JL; Kiesz RS; Bochenek A
JACC Cardiovasc Interv; 2016 Feb; 9(4):318-327. PubMed ID: 26892080
[TBL] [Abstract][Full Text] [Related]
8. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
[TBL] [Abstract][Full Text] [Related]
9. Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry.
Rodriguez AE; Maree AO; Mieres J; Berrocal D; Grinfeld L; Fernandez-Pereira C; Curotto V; Rodriguez-Granillo A; O'Neill W; Palacios IF
Eur Heart J; 2007 Sep; 28(17):2118-25. PubMed ID: 17656352
[TBL] [Abstract][Full Text] [Related]
10. Comparative long-term efficacy and safety of drug-eluting stent versus coronary artery bypass grafting in ostial left main coronary artery disease: analysis of the MAIN-COMPARE registry.
Lee SW; Kim SH; Kim SO; Han S; Kim YH; Park DW; Kang SJ; Lee CW; Park SW; Park SJ
Catheter Cardiovasc Interv; 2012 Aug; 80(2):206-12. PubMed ID: 22234884
[TBL] [Abstract][Full Text] [Related]
11. Two-year outcomes after treatment of severely calcified coronary lesions with the orbital atherectomy system and the impact of stent types: Insight from the ORBIT II trial.
Généreux P; Bettinger N; Redfors B; Lee AC; Kim CY; Lee MS; Shlofmitz RA; Moses JW; Stone GW; Chambers JW
Catheter Cardiovasc Interv; 2016 Sep; 88(3):369-77. PubMed ID: 27084293
[TBL] [Abstract][Full Text] [Related]
12. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.
Chen SL; Han YL; Zhang YJ; Ye F; Liu HW; Zhang JJ; Xu B; Jiang TM; Zhou YJ; Lv SZ
JACC Cardiovasc Interv; 2013 Dec; 6(12):1233-41. PubMed ID: 24239199
[TBL] [Abstract][Full Text] [Related]
13. Comparable clinical safety and efficacy of biodegradable versus durable polymer paclitaxel eluting stents despite shorter dual antiplatelet therapy: insights from a multicenter, propensity score-matched registry.
Buszman PP; Orlik B; Trela B; Milewski K; Kozlowski M; Pruski M; Drzewiecki J; Peppas A; Granada JF; Kaluza GL; Buszman PE
Catheter Cardiovasc Interv; 2013 Sep; 82(3):E155-62. PubMed ID: 23109067
[TBL] [Abstract][Full Text] [Related]
14. Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry.
Toyofuku M; Kimura T; Morimoto T; Hayashi Y; Shiode N; Nishikawa H; Nakao K; Shirota K; Kawai K; Hiasa Y; Kadota K; Nozaki Y; Isshiki T; Sone T; Mitsudo K;
JACC Cardiovasc Interv; 2013 Jul; 6(7):654-63. PubMed ID: 23866178
[TBL] [Abstract][Full Text] [Related]
15. Modifying angiographic syntax score according to PCI strategy: lessons learnt from ERACI IV Study.
Rodriguez AE; Fernandez-Pereira C; Mieres J; Santaera O; Antoniucci D;
Cardiovasc Revasc Med; 2015; 16(7):418-20. PubMed ID: 26254552
[TBL] [Abstract][Full Text] [Related]
16. 1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA Registries.
Tamburino C; Capranzano P; Gori T; Latib A; Lesiak M; Nef H; Caramanno G; Naber C; Mehilli J; Di Mario C; Sabaté M; Münzel T; Colombo A; Araszkiewicz A; Wiebe J; Geraci S; Jensen C; Mattesini A; Brugaletta S; Capodanno D
JACC Cardiovasc Interv; 2016 Mar; 9(5):440-9. PubMed ID: 26875648
[TBL] [Abstract][Full Text] [Related]
17. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
Gyöngyösi M; Christ G; Lang I; Kreiner G; Sochor H; Probst P; Neunteufl T; Badr-Eslam R; Winkler S; Nyolczas N; Posa A; Leisch F; Karnik R; Siostrzonek P; Harb S; Heigert M; Zenker G; Benzer W; Bonner G; Kaider A; Glogar D;
JACC Cardiovasc Interv; 2009 Aug; 2(8):718-27. PubMed ID: 19695539
[TBL] [Abstract][Full Text] [Related]
18. Comparative Effectiveness and Safety of New-Generation Versus Early-Generation Drug-Eluting Stents According to Complexity of Coronary Artery Disease: A Patient-Level Pooled Analysis of 6,081 Patients.
Piccolo R; Pilgrim T; Heg D; Franzone A; Rat-Wirtzler J; Räber L; Silber S; Serruys PW; Jüni P; Windecker S
JACC Cardiovasc Interv; 2015 Nov; 8(13):1657-66. PubMed ID: 26585615
[TBL] [Abstract][Full Text] [Related]
19. Two-year clinical outcomes of patients with overlapping second-generation drug-eluting stents for treatment of long coronary artery lesions: comparison of everolimus-eluting stents with resolute zotarolimus-eluting stents.
Li XT; Sun H; Zhang DP; Xu L; Ni ZH; Xia K; Liu Y; Chi YH; He JF; Li WM; Wang HS; Wang LF; Yang XC
Coron Artery Dis; 2014 Aug; 25(5):405-11. PubMed ID: 24584031
[TBL] [Abstract][Full Text] [Related]
20. Comparison Between 1- and 2-Stent Strategies in Unprotected Distal Left Main Disease: The Milan and New-Tokyo Registry.
Takagi K; Naganuma T; Chieffo A; Fujino Y; Latib A; Tahara S; Ishiguro H; Montorfano M; Carlino M; Kawamoto H; Kurita N; Hozawa K; Nakamura S; Nakamura S; Colombo A
Circ Cardiovasc Interv; 2016 Nov; 9(11):. PubMed ID: 27810964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
